Results

Total Results: 839 records

Showing results for "phase".

121. Effective Health Care (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/TND_0263_12-28-2007.pdf
     January 01, 2007 - populations, interventions, comparators, and outcomes, will be further developed in the refinement phase

122. PREGNANCY, INCLUDING PRETERM BIRTH #12 (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pregnancy-horizon-scan-high-impact-1406.pdf
     June 01, 2014 - inclusion are those interventions expected to be within 0–3 years of potential diffusion (e.g., in phase … Results The table below lists the one topic for which (1) preliminary phase III data were available; … These topics were ineligible for consideration in this report because no phase III data were available

123. #14 SUBSTANCE ABUSE (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/substance-abuse-horizon-scan-high-impact-1306.pdf
     June 01, 2013 - inclusion are those interventions expected to be within 0–4 years of potential diffusion (e.g., in phase … priority area this time (among the 11 topics being tracked as of May 18, 2013) for which (1) preliminary phase … The 6-month buprenorphine implant completed phase III trials, one of which was funded by the National

124. #14 SUBSTANCE ABUSE (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/substance-abuse-horizon-scan-high-impact-1512.pdf
     December 01, 2015 - inclusion are those interventions expected to be within 0–3 years of potential diffusion (e.g., in phase … Results The table below lists the four topics for which (1) preliminary phase III data for drugs or … Recently completed unphased, phase II, and phase IV clinical studies reported that daily oral zonisamide … In a phase III trial sponsored by the University of Pittsburgh (Pittsburgh, PA) and its affiliated … , a University of Pittsburgh (Pittsburgh, PA)-based research group reported results from a larger phase

125. DEMENTIA INCLUDING ALZHEIMER'S #04 (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/dementia-horizon-scan-high-impact-1412.pdf
     February 01, 2015 - inclusion are those interventions expected to be within 0–3 years of potential diffusion (e.g., in phase … Results The table below lists the two topics for which (1) preliminary phase III data for drugs were … this period, primarily due to failure to meet stated endpoints or demonstrate treatment efficacy in phase … and two beta-amyloid precursor protein site–cleaving enzyme (BACE) inhibitors, currently in late-phase … The latter cooperative sponsors the largest ongoing trial, a phase II/III trial investigating intranasal

126. PEPTIC ULCER #11 (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/peptic-ulcer-horizon-scan-high-impact-1406.pdf
     June 01, 2014 - inclusion are those interventions expected to be within 0–3 years of potential diffusion (e.g., in phase … Results The table below lists the one topic for which (1) preliminary phase III data for drugs were … Phase III trials conducted to obtain FDA approval reported that patients with SBS treated with teduglutide … Of the 566 subjects, 173 subjects were treated in Phase 3 SBS studies (134/173 [77%] at the dose of … Phase 3 Gattex (teduglutide) data highlight potential new treatment for adults with short bowel syndrome

127. Evidence-based Practice Center Systematic Review Protocol (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/head-neck-cancer_disposition-comments.pdf
     May 27, 2010 - The reference is: First results of a phase III multicenter randomized controlled trial of intensity … All three randomized studies, as well as all phase II-like and retrospective comparisons, report improved … Besides careful phase I-II studies of dose escalation, a policy of delivering higher doses using IMRT … In addition, two phase III RTOG trials (0522 and 0234) have 3DRT and IMRT treatment populations which … Besides careful phase I-II studies of dose escalation, a policy of delivering higher doses using

128. Effective Health Care (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/TND_0161_09-01-2009.pdf
     January 01, 2009 - populations, interventions, comparators, and outcomes, will be further developed in the refinement phase

129. Effective Health Care (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/TND_0119_06-17-2009.pdf
     January 01, 2009 - populations, interventions, comparators, and outcomes, will be further developed in the refinement phase

130. Effective Health Care (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/TND_0456_07-27-2011.pdf
     January 01, 2011 - populations, interventions, comparators, and outcomes, will be further developed in the refinement phase

131. Effective Health Care (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/TND_0136_07-21-2009.pdf
     January 01, 2009 - populations, interventions, comparators, and outcomes, will be further developed in the refinement phase

132. Effective Health Care (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/TND_0064_11-23-2008.pdf
     January 01, 2008 - populations, interventions, comparators, and outcomes, will be further developed in the refinement phase

133. Effective Health Care (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/TND_0288_03-10-2008.pdf
     January 01, 2008 - populations, interventions, comparators, and outcomes, will be further developed in the refinement phase

134. Topic 0548 Comparative Effectiveness of Treatments for MDD NSD FINAL SJ (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/TND-0647-13114.pdf
     June 21, 2013 - populations, interventions, comparators, and outcomes, will be further developed in the refinement phase

135. Palliative radiation therapy for bone metastases: Update of an ASTRO Evidence-Based Guideline (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/topic-nomination-bone-metastases.pdf
     February 01, 2017 - Longer schedules, such as 30 Gy in 10 fractions in the phase 3 trial by Patchell, continue to be most … A randomized, dose-response, multicenter phase II study of radium-223 chloride for the palliation of … Two-year survival follow-up of the randomized, double-blind, placebo-controlled phase II study of radium … Phase 2 study of a high dose of 186Re-HEDP for bone pain palliation in patients with widespread skeletal … RTOG 0631 Protocol Information-Phase II/III Study of Image-Guided Radiosurgery/SBRT for Localized Spine

136. Topic 0590 Strategies to Treat and Manage Infantile Hemangioma NSD FINAL_SJ (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/TND_0715-140408.pdf
     May 29, 2025 - populations, interventions, comparators, and outcomes, will be further developed in the refinement phase

137. Tx-For-Localized-Prostate-Cancer Surveillanceassesment 20120614 (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/tx-for-localized-prostate-cancer_surveillanceassesment_20120614.pdf
     May 01, 2012 - or without radiotherapy, in locally advanced prostate cancer (SPCG-7/SFUO-3): an open randomised phase … A prospective phase III randomized trial of hypofractionation versus conventional fractionation in … Phase III trial of long-term adjuvant androgen deprivation after neoadjuvant hormonal cytoreduction … I, Clinical Trial, Phase II, Clinical Trial, Phase III, Clinical Trial, Phase IV NOT metasta*[ti] … I, Clinical Trial, Phase II, Clinical Trial, Phase III, Clinical Trial, Phase IV SEARCH STRATEGY

138. Tx-For-Localized-Prostate-Cancer Surveillanceassesment 20120614 (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/tx-for-localized-prostate-cancer_surveillanceassesment_20120614.pdf
     May 01, 2012 - or without radiotherapy, in locally advanced prostate cancer (SPCG-7/SFUO-3): an open randomised phase … A prospective phase III randomized trial of hypofractionation versus conventional fractionation in … Phase III trial of long-term adjuvant androgen deprivation after neoadjuvant hormonal cytoreduction … I, Clinical Trial, Phase II, Clinical Trial, Phase III, Clinical Trial, Phase IV NOT metasta*[ti] … I, Clinical Trial, Phase II, Clinical Trial, Phase III, Clinical Trial, Phase IV SEARCH STRATEGY

139. Diabetes Mellitus (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/07_diabetes_potential_high_impact_june_2012.pdf
     January 01, 2012 - inclusion are those interventions expected to be within 0–4 years of potential diffusion (e.g., in phase … Results The table below lists the 15 topics for which (1) preliminary phase III data for drugs or phase … In September 2011, the company announced plans for its phase III trial after releasing final 48-week … results from its phase II trial. … Intarcia presents positive ITCA 650 phase 2 study results for type 2 diabetes at EASD.

140. Evidence-based Practice Center Systematic Review Protocol (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/juvenile-arthritis-dmards_disposition-comments.pdf
     September 01, 2011 - In adverse event analysis, page 45, why weren't open label run-in phase data in the withdrawal studies … This was a 3- phase study (Period A) was a 4-month, open-label phase that determined response to abatacept … The second phase (Period B) was a 6-month, randomized, double-blind, parallel-dosing, placebo-controlled … During the double-blind phase (Period B), serious adverse events occurred in two patients in the placebo … E.g., the etanercept study (Lovell, et al.) used an active run-in phase before randomization.